Dr. David Garcia is Professor of Internal Medicine, Division of Hematology/Oncology, at the University of New Mexico (UNM) Health Sciences Center. He is director of Cancer and Thrombosis at the UNM Cancer Center and has been the director of the Anticoagulation Management Service at University Hospital for more than 10 years. Dr. Garcia has been an investigator in numerous clinical trials of anticoagulant medications and he is currently (or has been) a steering committee member for several multi-center trials involving novel anticoagulants, warfarin reversal strategies and perioperative anticoagulation. Dr. Garcia was the Editor or Deputy Editor of 2 chapters in the Evidence-based Clinical Practice Guideline on Anti-thrombotic Therapy published in February 2012 by the American College of Chest Physicians. Dr. Garcia is the President of the Anticoagulation Forum, a national interest group focused on the prevention and treatment of thromboembolic disease. Dr. Garcia's primary research interests include the relationship of cancer and thrombosis, the treatment of warfarin-associated coagulopathy, and the risks and benefits of peri-procedural anticoagulation. He has authored or coauthored more than 40 peer-reviewed publications in high-impact journals such as The New England Journal of Medicine, Blood, Archives of Internal Medicine, Chest, Thrombosis and Thrombolysis, the British Journal of Hematology, and the Journal of the American College of Cardiology.